Bioventus's market cap is currently $807.49M. The company's EPS TTM is $-0.617; its P/E ratio is ―; Bioventus is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 512.35M	$ 512.12M	$ 430.90M	$ 321.16M	$ 340.14M
Gross Profit	$ 328.19M	$ 331.08M	$ 302.71M	$ 233.52M	$ 249.21M
Operating Income	$ -81.72M	$ -35.68M	$ 17.72M	$ 21.24M	$ 31.19M
EBITDA	$ -23.07M	$ -109.20M	$ 51.81M	$ 50.44M	$ 61.58M
Net Income	$ -156.23M	$ -213.39M	$ 9.59M	$ 16.41M	$ 6.85M
Balance Sheet
Cash & Short-Term Investments	$ 36.96M	$ 31.81M	$ 43.93M	$ 86.84M	$ 64.52M
Total Assets	$ 810.91M	$ 1.37B	$ 1.23B	$ 494.47M	$ 472.41M
Total Debt	$ 394.85M	$ 418.07M	$ 357.68M	$ 188.38M	$ 197.97M
Net Debt	$ 357.88M	$ 386.25M	$ 313.75M	$ 101.54M	$ 133.44M
Total Liabilities	$ 589.79M	$ 1.03B	$ 692.07M	$ 350.31M	$ 326.79M
Stockholders' Equity	$ 173.59M	$ 316.58M	$ 458.92M	$ 142.24M	$ 142.98M
Cash Flow
Free Cash Flow	$ 7.98M	$ -25.06M	$ 15.62M	$ 51.13M	$ 32.37M
Operating Cash Flow	$ 15.34M	$ -13.54M	$ 22.99M	$ 71.80M	$ 40.71M
Investing Cash Flow	$ 15.81M	$ -116.44M	$ -283.76M	$ -20.50M	$ -7.91M
Financing Cash Flow	$ -26.65M	$ 62.08M	$ 273.37M	$ -29.57M	$ -10.95M

Currency in USD

Bioventus Earnings and Revenue History

Income Statement >

Bioventus Debt to Assets

Balance Sheet >

Bioventus Cash Flow

Cash Flow >

Bioventus Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing